Canopy Growth Full Year 2025 Earnings: Misses Expectations

Simply Wall St · 05/31 12:49

Canopy Growth (TSE:WEED) Full Year 2025 Results

Key Financial Results

  • Revenue: CA$269.0m (down 9.5% from FY 2024).
  • Net loss: CA$604.1m (loss widened by 25% from FY 2024).
  • CA$5.62 loss per share.
earnings-and-revenue-growth
TSX:WEED Earnings and Revenue Growth May 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Canopy Growth Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) also missed analyst estimates by 27%.

Looking ahead, revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Pharmaceuticals industry in Canada.

Performance of the Canadian Pharmaceuticals industry.

The company's shares are down 28% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Canopy Growth (at least 2 which are potentially serious), and understanding these should be part of your investment process.